Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Novartis AG (NVS) vs Twilio Inc (TWLO) Price & Performance

Novartis AGTrade
Twilio IncTrade

Price performance (Past 24H)

Key statistics

Novartis AG vs Twilio Inc — how do they compare? Novartis AG trades at $153.88 (market cap $290.25B), while Twilio Inc trades at $195.59 (market cap $31.15B). The key difference: Novartis AG is far larger — about 9.3× Twilio Inc's market cap, and Novartis AG pays a 3.17% dividend while Twilio Inc pays none. Which is the better fit depends on your goals.

NVSTWLO
Market Cap
$290.25B$31.15B
Sector
HealthTechnology
52-Week High
$168.62$236.64
52-Week Low
$113.50$92.44
Enterprise Value
$330.27B$29.87B
Dividend Yield
3.17%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Novartis AG

Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.

Read more on NVS

About Twilio Inc

Twilio Inc. is a cloud-based communication platform-as-a-service company offering communication building blocks that allow for a fully customized customer engagement experience spanning voice, video, chat, and SMS messaging. It does this through various application programming interfaces, or APIs, and prebuilt solution applications aimed at improving customer engagement. The company leverages its Super Network, a global network of carrier relationships, to facilitate high-speed, cost-effective communication.

Read more on TWLO